TTD | Drug: D0Z6GG

Drug General Information
Drug ID	D0Z6GG
Former ID	DNC014361
Drug Name	N-benzyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530923]
Structure		Download 2D MOL 3D MOL
Formula	C15H18N4
Canonical SMILES	C1CCN(C1)C2=NC=CC(=N2)NCC3=CC=CC=C3
InChI	1S/C15H18N4/c1-2-6-13(7-3-1)12-17-14-8-9-16-15(18-14)19-10-4-5-11-19/h1-3,6-9H,4-5,10-12H2,(H,16,17,18)
InChIKey	PGBNXXDXGXQQRQ-UHFFFAOYSA-N
PubChem Compound ID	46891014
Target and Pathway
Target(s)	Acetylcholinesterase	Target Info	Inhibitor	[530923]
KEGG Pathway	Glycerophospholipid metabolism
KEGG Pathway	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer Pathway
References
Ref 530923	Bioorg Med Chem Lett. 2010 Jun 15;20(12):3606-9. Epub 2010 Apr 28.Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors.
Ref 530923	Bioorg Med Chem Lett. 2010 Jun 15;20(12):3606-9. Epub 2010 Apr 28.Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information